{"id":"https://openalex.org/W2022720797","doi":"https://doi.org/10.1111/j.1365-2362.2008.01989.x","title":"A novel antagonist of prostaglandin D2 blocks the locomotion of eosinophils and basophils","display_name":"A novel antagonist of prostaglandin D2 blocks the locomotion of eosinophils and basophils","publication_year":2008,"publication_date":"2008-08-18","ids":{"openalex":"https://openalex.org/W2022720797","doi":"https://doi.org/10.1111/j.1365-2362.2008.01989.x","mag":"2022720797","pmid":"https://pubmed.ncbi.nlm.nih.gov/18837743"},"language":"en","primary_location":{"id":"doi:10.1111/j.1365-2362.2008.01989.x","doi":"https://doi.org/10.1111/j.1365-2362.2008.01989.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1365-2362.2008.01989.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2362.2008.01989.x","source":{"id":"https://openalex.org/S153084679","display_name":"European Journal of Clinical Investigation","issn_l":"0014-2972","issn":["0014-2972","1365-2362"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Clinical Investigation","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2362.2008.01989.x","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5030748994","display_name":"Julia F. Royer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I15766117","display_name":"University of Graz","ror":"https://ror.org/01faaaf77","country_code":"AT","type":"education","lineage":["https://openalex.org/I15766117"]},{"id":"https://openalex.org/I202276237","display_name":"Medical University of Graz","ror":"https://ror.org/02n0bts35","country_code":"AT","type":"education","lineage":["https://openalex.org/I202276237"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"J. F. Royer","raw_affiliation_strings":["Institute of Experimental and Clinical Pharmacology, Medical University Graz, Graz, Austria","Medical University Graz, Graz, Austria,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Experimental and Clinical Pharmacology, Medical University Graz, Graz, Austria","institution_ids":["https://openalex.org/I15766117","https://openalex.org/I202276237"]},{"raw_affiliation_string":"Medical University Graz, Graz, Austria,","institution_ids":["https://openalex.org/I202276237"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017526539","display_name":"Petra Schratl","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I202276237","display_name":"Medical University of Graz","ror":"https://ror.org/02n0bts35","country_code":"AT","type":"education","lineage":["https://openalex.org/I202276237"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"P. Schratl","raw_affiliation_strings":["Medical University Graz, Graz, Austria,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical University Graz, Graz, Austria,","institution_ids":["https://openalex.org/I202276237"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069145918","display_name":"Juan J. Carrillo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"J. J. Carrillo","raw_affiliation_strings":["AstraZeneca R & D Charnwood, Loughborough, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca R & D Charnwood, Loughborough, UK","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066404838","display_name":"Rachael Jupp","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"R. Jupp","raw_affiliation_strings":["AstraZeneca R & D Charnwood, Loughborough, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca R & D Charnwood, Loughborough, UK","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":null,"display_name":"J. Barker","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"J. Barker","raw_affiliation_strings":["AstraZeneca R & D Charnwood, Loughborough, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca R & D Charnwood, Loughborough, UK","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011798633","display_name":"Carol Weyman-Jones","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"C. Weyman\u2010Jones","raw_affiliation_strings":["AstraZeneca R & D Charnwood, Loughborough, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca R & D Charnwood, Loughborough, UK","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067923919","display_name":"Raj K. Beri","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"R. Beri","raw_affiliation_strings":["AstraZeneca R & D Charnwood, Loughborough, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca R & D Charnwood, Loughborough, UK","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112090903","display_name":"Carol A. Sargent","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"C. Sargent","raw_affiliation_strings":["AstraZeneca R & D Charnwood, Loughborough, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca R & D Charnwood, Loughborough, UK","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109307566","display_name":"J A Schmidt","orcid":"https://orcid.org/0009-0009-2090-4975","observed_orcids":["https://orcid.org/0009-0009-2090-4975"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"J. A. Schmidt","raw_affiliation_strings":["AstraZeneca R & D Charnwood, Loughborough, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca R & D Charnwood, Loughborough, UK","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024420848","display_name":"Doris Lang\u2010Loidolt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I202276237","display_name":"Medical University of Graz","ror":"https://ror.org/02n0bts35","country_code":"AT","type":"education","lineage":["https://openalex.org/I202276237"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"D. Lang\u2010Loidolt","raw_affiliation_strings":["Medical University Graz, Graz, Austria,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical University Graz, Graz, Austria,","institution_ids":["https://openalex.org/I202276237"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5006321692","display_name":"\u00c1kos Heinemann","orcid":"https://orcid.org/0000-0002-8554-2372","observed_orcids":["https://orcid.org/0000-0002-8554-2372"]},"institutions":[{"id":"https://openalex.org/I202276237","display_name":"Medical University of Graz","ror":"https://ror.org/02n0bts35","country_code":"AT","type":"education","lineage":["https://openalex.org/I202276237"]}],"countries":["AT"],"is_corresponding":true,"raw_author_name":"A. Heinemann","raw_affiliation_strings":["Medical University Graz, Graz, Austria,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical University Graz, Graz, Austria,","institution_ids":["https://openalex.org/I202276237"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5006321692"],"corresponding_institution_ids":["https://openalex.org/I202276237"],"apc_list":{"value":4100,"currency":"USD","value_usd":4100},"apc_paid":null,"fwci":4.966,"has_fulltext":true,"cited_by_count":36,"citation_normalized_percentile":{"value":0.95065287,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"38","issue":"9","first_page":"663","last_page":"671"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":0.8628000020980835,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":0.8628000020980835,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11346","display_name":"Mast cells and histamine","score":0.11829999834299088,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.007000000216066837,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/crth2-antagonist","display_name":"CRTH2 antagonist","score":0.9210000038146973},{"id":"https://openalex.org/keywords/prostaglandin-d2","display_name":"prostaglandin D2","score":0.9639999866485596},{"id":"https://openalex.org/keywords/eosinophil-chemotaxis","display_name":"eosinophil chemotaxis","score":0.9110000133514404},{"id":"https://openalex.org/keywords/platelet-aggregation","display_name":"platelet aggregation","score":0.8650000095367432},{"id":"https://openalex.org/keywords/ramatroban","display_name":"ramatroban","score":0.9459999799728394},{"id":"https://openalex.org/keywords/allergic-diseases","display_name":"allergic diseases","score":0.8489999771118164},{"id":"https://openalex.org/keywords/th2-cells","display_name":"Th2 cells","score":0.6970000267028809}],"concepts":[{"id":"https://openalex.org/C2777037409","wikidata":"https://www.wikidata.org/wiki/Q107238","display_name":"Eosinophil","level":3,"score":0.7998937964439392},{"id":"https://openalex.org/C2777456892","wikidata":"https://www.wikidata.org/wiki/Q107988","display_name":"Basophil","level":4,"score":0.7681293487548828},{"id":"https://openalex.org/C2777361909","wikidata":"https://www.wikidata.org/wiki/Q419750","display_name":"Prostaglandin D2","level":3,"score":0.6332242488861084},{"id":"https://openalex.org/C54166955","wikidata":"https://www.wikidata.org/wiki/Q658145","display_name":"Chemotaxis","level":3,"score":0.6144527196884155},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5244253873825073},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.5196743607521057},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.49153932929039},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.4874598979949951},{"id":"https://openalex.org/C2778122271","wikidata":"https://www.wikidata.org/wiki/Q410943","display_name":"Receptor antagonist","level":4,"score":0.4688205420970917},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4663523733615875},{"id":"https://openalex.org/C2778815084","wikidata":"https://www.wikidata.org/wiki/Q79803","display_name":"Guinea pig","level":2,"score":0.46424731612205505},{"id":"https://openalex.org/C2780664492","wikidata":"https://www.wikidata.org/wiki/Q209717","display_name":"Prostaglandin","level":2,"score":0.45787426829338074},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.41421836614608765},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4033068120479584},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.33853036165237427},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.29264524579048157},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2184426486492157},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.20565354824066162},{"id":"https://openalex.org/C141105273","wikidata":"https://www.wikidata.org/wiki/Q79455","display_name":"Immunoglobulin E","level":3,"score":0.19156357645988464},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.1647110879421234},{"id":"https://openalex.org/C2776042228","wikidata":"https://www.wikidata.org/wiki/Q35869","display_name":"Asthma","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001491","descriptor_name":"Basophils","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D001491","descriptor_name":"Basophils","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D001853","descriptor_name":"Bone Marrow","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002227","descriptor_name":"Carbazoles","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D002465","descriptor_name":"Cell Movement","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D002465","descriptor_name":"Cell Movement","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D002633","descriptor_name":"Chemotaxis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D002633","descriptor_name":"Chemotaxis","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D006168","descriptor_name":"Guinea Pigs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010975","descriptor_name":"Platelet Aggregation Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011971","descriptor_name":"Receptors, Immunologic","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D011982","descriptor_name":"Receptors, Prostaglandin","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D015230","descriptor_name":"Prostaglandin D2","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D018418","descriptor_name":"Th2 Cells","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.1365-2362.2008.01989.x","doi":"https://doi.org/10.1111/j.1365-2362.2008.01989.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1365-2362.2008.01989.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2362.2008.01989.x","source":{"id":"https://openalex.org/S153084679","display_name":"European Journal of Clinical Investigation","issn_l":"0014-2972","issn":["0014-2972","1365-2362"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Clinical Investigation","raw_type":"journal-article"},{"id":"pmid:18837743","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18837743","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European journal of clinical investigation","raw_type":"Comparative Study"}],"best_oa_location":{"id":"doi:10.1111/j.1365-2362.2008.01989.x","doi":"https://doi.org/10.1111/j.1365-2362.2008.01989.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1365-2362.2008.01989.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2362.2008.01989.x","source":{"id":"https://openalex.org/S153084679","display_name":"European Journal of Clinical Investigation","issn_l":"0014-2972","issn":["0014-2972","1365-2362"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Clinical Investigation","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9476000070571899,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"score":0.5299999713897705,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2290085877","display_name":null,"funder_award_id":"11967","funder_id":"https://openalex.org/F4320322325","funder_display_name":"Oesterreichische Nationalbank"},{"id":"https://openalex.org/G8632719330","display_name":null,"funder_award_id":"10934","funder_id":"https://openalex.org/F4320322325","funder_display_name":"Oesterreichische Nationalbank"}],"funders":[{"id":"https://openalex.org/F4320321181","display_name":"Austrian Science Fund","ror":"https://ror.org/013tf3c58"},{"id":"https://openalex.org/F4320322325","display_name":"Oesterreichische Nationalbank","ror":"https://ror.org/00nkcmy90"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2022720797.pdf","grobid_xml":"https://content.openalex.org/works/W2022720797.grobid-xml"},"referenced_works_count":41,"referenced_works":["https://openalex.org/W70713675","https://openalex.org/W180810881","https://openalex.org/W1519407136","https://openalex.org/W1779958125","https://openalex.org/W1859491149","https://openalex.org/W1865300293","https://openalex.org/W1963798077","https://openalex.org/W1973502458","https://openalex.org/W1982158616","https://openalex.org/W1994424025","https://openalex.org/W1995244403","https://openalex.org/W2012768613","https://openalex.org/W2017485498","https://openalex.org/W2018464738","https://openalex.org/W2020627803","https://openalex.org/W2030536920","https://openalex.org/W2030634089","https://openalex.org/W2036880526","https://openalex.org/W2047211765","https://openalex.org/W2052104184","https://openalex.org/W2063665402","https://openalex.org/W2066882388","https://openalex.org/W2074808191","https://openalex.org/W2082003115","https://openalex.org/W2083616068","https://openalex.org/W2084624382","https://openalex.org/W2089980371","https://openalex.org/W2092815906","https://openalex.org/W2098967308","https://openalex.org/W2101035994","https://openalex.org/W2103069823","https://openalex.org/W2111777001","https://openalex.org/W2128663076","https://openalex.org/W2140942460","https://openalex.org/W2150068375","https://openalex.org/W2154263136","https://openalex.org/W2159923131","https://openalex.org/W2160634538","https://openalex.org/W2164190312","https://openalex.org/W2166893697","https://openalex.org/W2312870247"],"related_works":["https://openalex.org/W2164102008","https://openalex.org/W2128740510","https://openalex.org/W2020627803","https://openalex.org/W2150068375","https://openalex.org/W1480634485","https://openalex.org/W2166893697","https://openalex.org/W1865300293","https://openalex.org/W2055954501","https://openalex.org/W7095304654","https://openalex.org/W1859491149"],"abstract_inverted_index":{"BACKGROUND:":[0],"Chemoattractant":[1],"receptor":[2],"homologous":[3],"molecule":[4],"of":[5,16,38,129,141,150,158,198,202,210,223],"Th2":[6],"cells":[7,110],"(CRTH2)":[8],"has":[9],"been":[10],"shown":[11],"to":[12,33,93,101,119],"mediate":[13],"the":[14,35,87,126,137,153,159,200,207,221],"chemotaxis":[15],"eosinophils,":[17],"basophils":[18,145],"and":[19,52,63,68,73,103,111,114,144,167,204,206],"Th2-type":[20],"T":[21],"lymphocytes.":[22],"The":[23,81,148],"major":[24],"mast":[25],"cell":[26],"product":[27],"prostaglandin":[28],"(PG)":[29],"D(2)":[30],"is":[31,190,196],"considered":[32],"be":[34,218],"principal":[36],"ligand":[37],"CRTH2.":[39],"MATERIALS":[40],"AND":[41],"METHODS:":[42],"We":[43],"developed":[44],"a":[45,191],"novel":[46],"CRTH2":[47,89,106,193],"antagonist,":[48],"AZ11665362":[49,96,121,134,178,189,215],"[2,5-dimethyl-3-(8-methylquinolin-4-yl)-1H-indole-1-yl]acetic":[50],"acid,":[51],"characterized":[53],"its":[54],"efficacy":[55],"in":[56,59,108,138],"binding":[57],"assay":[58,67],"HEK293":[60,109],"cells,":[61],"eosinophil":[62,74,113],"basophil":[64,115],"shape":[65,116],"change":[66,117],"migration":[69,140,201],"assay,":[70],"platelet":[71,130],"aggregation":[72],"release":[75,149],"from":[76,152,212],"guinea":[77,104,160],"pig":[78,105,161],"bone":[79,213],"marrow.":[80,214],"effects":[82],"were":[83],"compared":[84],"with":[85,98],"ramatroban,":[86],"sole":[88],"antagonist":[90,194],"clinically":[91],"available":[92],"date.":[94],"RESULTS:":[95],"bound":[97],"high":[99],"affinity":[100],"human":[102,142],"expressed":[107],"antagonized":[112],"responses":[118],"PGD(2).":[120,147],"was":[122,162,170,179],"without":[123],"effect":[124,169],"on":[125],"PGD(2)-induced":[127],"inhibition":[128],"aggregation.":[131],"In":[132,174],"contrast,":[133],"effectively":[135],"inhibited":[136],"vitro":[139],"eosinophils":[143,151,203,211],"towards":[146],"isolated":[154],"perfused":[155],"hind":[156],"limb":[157],"potently":[163],"stimulated":[164],"by":[165,172],"PGD(2),":[166],"this":[168],"prevented":[171],"AZ11665362.":[173],"all":[175],"assays":[176],"tested,":[177],"at":[180],"least":[181],"10":[182],"times":[183],"more":[184],"potent":[185,192],"than":[186],"ramatroban.":[187],"CONCLUSIONS:":[188],"that":[195],"capable":[197],"blocking":[199],"basophils,":[205],"rapid":[208],"mobilization":[209],"might":[216],"hence":[217],"useful":[219],"for":[220],"treatment":[222],"allergic":[224],"diseases.":[225]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":3},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":3},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}